Subscribe
shutterstock_728418391_casimiro_pt
casimiropt / Shutterstock.com
19 September 2019AmericasSarah Morgan

Duke and Allergan escape antitrust claims in Akorn suit

A US judge dismissed antitrust counterclaims brought against Allergan and Duke University earlier this week, in a lawsuit the pair filed against generics maker Akorn.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Duke University and Allergan drop Alcon dispute
9 October 2018   North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Duke University and Allergan drop Alcon dispute
9 October 2018   North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware.

More on this story

Americas
Duke University and Allergan drop Alcon dispute
9 October 2018   North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent